Fuji, Japan

Eiji Kodama


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1984-1986

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eiji Kodama: Innovator in Cephalosporin Compounds

Introduction

Eiji Kodama is a notable inventor based in Fuji, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin compounds. With a total of 3 patents to his name, his work has had a considerable impact on antibacterial treatments.

Latest Patents

Kodama's latest patents include innovative cephalosporin compounds that exhibit antibacterial activity. One of his notable inventions is a novel cephalosporin compound represented by a specific general formula, where R₁ can be an amino group or a protected amino group. Another significant patent involves a cephalosporin compound characterized by a general formula where X can be a hydrogen atom, a chlorine atom, a methyl group, a methoxy group, an acetoxymethyl group, or a specific heterocyclic ring containing nitrogen, oxygen, or sulfur atoms.

Career Highlights

Eiji Kodama has been associated with Asahi Kasei Kogyo Kabushiki Kaisha, a leading company in the chemical and pharmaceutical industry. His work has been instrumental in advancing the company's research and development efforts in antibacterial agents.

Collaborations

Throughout his career, Kodama has collaborated with esteemed colleagues such as Joji Nishikido and Mitsuru Shibukawa. These partnerships have fostered innovation and contributed to the successful development of new pharmaceutical compounds.

Conclusion

Eiji Kodama's contributions to the field of cephalosporin compounds highlight his role as a significant inventor in the pharmaceutical industry. His innovative work continues to influence antibacterial treatments and showcases the importance of collaboration in scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…